Abilify Maintena: Key Information and Considerations
Abilify Maintena is a long-acting injectable aripiprazole used for schizophrenia and bipolar I disorder that requires initial oral supplementation and offers improved adherence. It works by modulating dopamine and serotonin, but carries potential side effects and contraindications that necessitate careful monitoring and management.
Abilify Maintena is an injectable, long-acting form of aripiprazole used for the treatment of schizophrenia and bipolar I disorder. It offers a sustained release of the medication, helping to improve medication adherence compared to daily oral formulations, thereby potentially reducing the risk of relapse.
The drug works as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors. This mechanism of action helps to stabilize dopamine levels in the brain and modulate serotonin activity, which are believed to play a role in the pathophysiology of schizophrenia and bipolar disorder.
Following the initial injection, oral aripiprazole supplementation is required for 14 days to maintain adequate plasma concentrations. This is because it takes time for Abilify Maintena to reach therapeutic levels in the body after the first injection.
Common side effects of Abilify Maintena include weight gain, akathisia (restlessness), injection site pain, and somnolence. Patients should be monitored for these and other potential adverse effects, and appropriate management strategies should be implemented.
Contraindications and warnings should be carefully considered before initiating treatment. These may include hypersensitivity to aripiprazole, history of neuroleptic malignant syndrome, and tardive dyskinesia. Dosage adjustments may be needed for patients with hepatic or renal impairment or those taking interacting medications.
Abilify Maintena offers a convenient once-monthly administration, which can significantly enhance patient compliance. Consistent dosing can lead to improved symptom control and overall better management of the mental health condition.
Key points
- Abilify Maintena is a long-acting injectable aripiprazole.
- Oral supplementation is needed for 14 days after the first injection.
- Monitor for side effects like weight gain and akathisia.